Again, as reported in Table 1, the protein-fusion strategy against cancer has been used many other times with RNase 1 (213–215) and ONC (220), but also with BS-RNase (226) and EDN (225), producing cytotoxic derivatives. Here, RNASE1 is linked to cancer.